1. Home
  2. IVA vs REE Comparison

IVA vs REE Comparison

Compare IVA & REE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVA
  • REE
  • Stock Information
  • Founded
  • IVA 2011
  • REE 2011
  • Country
  • IVA France
  • REE Israel
  • Employees
  • IVA N/A
  • REE N/A
  • Industry
  • IVA Biotechnology: Pharmaceutical Preparations
  • REE Auto Manufacturing
  • Sector
  • IVA Health Care
  • REE Consumer Discretionary
  • Exchange
  • IVA Nasdaq
  • REE Nasdaq
  • Market Cap
  • IVA 127.0M
  • REE 151.4M
  • IPO Year
  • IVA 2020
  • REE N/A
  • Fundamental
  • Price
  • IVA $2.84
  • REE $7.76
  • Analyst Decision
  • IVA Strong Buy
  • REE Buy
  • Analyst Count
  • IVA 4
  • REE 3
  • Target Price
  • IVA $13.25
  • REE $11.00
  • AVG Volume (30 Days)
  • IVA 10.9K
  • REE 29.2K
  • Earning Date
  • IVA 03-26-2025
  • REE 03-26-2025
  • Dividend Yield
  • IVA N/A
  • REE N/A
  • EPS Growth
  • IVA N/A
  • REE N/A
  • EPS
  • IVA N/A
  • REE N/A
  • Revenue
  • IVA $20,652,523.00
  • REE $626,000.00
  • Revenue This Year
  • IVA N/A
  • REE N/A
  • Revenue Next Year
  • IVA $197.46
  • REE $21,460.67
  • P/E Ratio
  • IVA N/A
  • REE N/A
  • Revenue Growth
  • IVA N/A
  • REE N/A
  • 52 Week Low
  • IVA $1.53
  • REE $2.91
  • 52 Week High
  • IVA $4.50
  • REE $11.72
  • Technical
  • Relative Strength Index (RSI)
  • IVA 69.74
  • REE 41.28
  • Support Level
  • IVA $2.58
  • REE $7.62
  • Resistance Level
  • IVA $2.80
  • REE $8.38
  • Average True Range (ATR)
  • IVA 0.15
  • REE 0.43
  • MACD
  • IVA 0.04
  • REE -0.02
  • Stochastic Oscillator
  • IVA 81.31
  • REE 13.46

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

About REE REE Automotive Ltd.

REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is developing REEcorner technology which packs critical vehicle components into a single compact module positioned between the chassis and the wheel as well as building commercial Electric Vehicles (EV) leveraging REEcorner technology. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.

Share on Social Networks: